Abstract

BAY, Luisa B et al. Infantile-onset Pompe disease: Diagnosis and management. Arch. argent. pediatr. [online]. 2019, vol.117, n.4, pp.271-278. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2019.271.

Pompe disease, also known as acid maltase deficiency or glycogenosis type II, is a rare severe, autosomal, recessive, and progressive genetic disorder caused by deficiency in alpha-glucosidase. The classic infantile-onset is the most broadly known form of Pompe disease, which presents with severe heart involvement and clear hypotonia, while the non-classic presentation occurs with early motor involvement. Late-onset Pompe disease develops in adults, but it may also occur during childhood or adolescence. Here we update the available clinical and diagnostic findings because an early management with enzyme replacement therapy may improve patients' survival and quality of life. We also review the benefits and adverse effects of available treatments and new lines of therapeutic research.

Keywords : Pompe disease; Glycogenosis type II; Cardiomyopathies; Muscular hypotonia; Motor disorders.

        · abstract in Spanish     · text in Spanish     · English ( pdf ) | Spanish ( pdf )